HK1034079A1 - Tetrahydroquinoline derivatives as glycine antagonists - Google Patents

Tetrahydroquinoline derivatives as glycine antagonists

Info

Publication number
HK1034079A1
HK1034079A1 HK01104579A HK01104579A HK1034079A1 HK 1034079 A1 HK1034079 A1 HK 1034079A1 HK 01104579 A HK01104579 A HK 01104579A HK 01104579 A HK01104579 A HK 01104579A HK 1034079 A1 HK1034079 A1 HK 1034079A1
Authority
HK
Hong Kong
Prior art keywords
tetrahydroquinoline derivatives
glycine antagonists
antagonists
glycine
tetrahydroquinoline
Prior art date
Application number
HK01104579A
Other languages
English (en)
Inventor
Romano Di Fabio
Original Assignee
Glaxosmithkline Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9812408.4A external-priority patent/GB9812408D0/en
Priority claimed from GBGB9812410.0A external-priority patent/GB9812410D0/en
Application filed by Glaxosmithkline Spa filed Critical Glaxosmithkline Spa
Publication of HK1034079A1 publication Critical patent/HK1034079A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
HK01104579A 1998-06-10 2001-07-03 Tetrahydroquinoline derivatives as glycine antagonists HK1034079A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9812408.4A GB9812408D0 (en) 1998-06-10 1998-06-10 Heterocyclic compounds
GBGB9812410.0A GB9812410D0 (en) 1998-06-10 1998-06-10 Heterocyclic derivatives
PCT/EP1999/003936 WO1999064411A1 (en) 1998-06-10 1999-06-08 Tetrahydroquinoline derivatives as glycine antagonists

Publications (1)

Publication Number Publication Date
HK1034079A1 true HK1034079A1 (en) 2001-10-12

Family

ID=26313826

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01104579A HK1034079A1 (en) 1998-06-10 2001-07-03 Tetrahydroquinoline derivatives as glycine antagonists

Country Status (34)

Country Link
US (3) US6362199B1 (es)
EP (1) EP1086093B1 (es)
JP (1) JP2002517492A (es)
KR (1) KR100586762B1 (es)
CN (1) CN1173970C (es)
AP (1) AP2000002008A0 (es)
AR (1) AR018632A1 (es)
AT (1) ATE301650T1 (es)
AU (1) AU753867B2 (es)
BG (1) BG105123A (es)
BR (1) BR9911145A (es)
CA (1) CA2334727C (es)
CO (1) CO5080785A1 (es)
CZ (1) CZ293605B6 (es)
DE (1) DE69926632T2 (es)
DK (1) DK1086093T3 (es)
EA (1) EA003276B1 (es)
EE (1) EE200000733A (es)
ES (1) ES2249010T3 (es)
HK (1) HK1034079A1 (es)
HR (1) HRP20000845A2 (es)
HU (1) HUP0102767A3 (es)
ID (1) ID27845A (es)
IL (2) IL140062A0 (es)
IS (1) IS5746A (es)
MY (1) MY125037A (es)
NO (1) NO321904B1 (es)
NZ (1) NZ508638A (es)
OA (1) OA11564A (es)
PE (1) PE20000724A1 (es)
PL (1) PL197160B1 (es)
TR (1) TR200003652T2 (es)
TW (1) TWI229079B (es)
WO (1) WO1999064411A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125037A (en) * 1998-06-10 2006-07-31 Glaxo Wellcome Spa 1,2,3,4 tetrahydroquinoline derivatives
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
GB9929037D0 (en) * 1999-12-08 2000-02-02 Glaxo Wellcome Spa Heterocyclic derivatives
DE10000311A1 (de) 2000-01-05 2001-07-12 Gruenenthal Gmbh Aminomethyl-Phonyl-Cyclohexanonderivate
DE10005302A1 (de) * 2000-02-07 2002-01-17 Gruenenthal Gmbh Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate
DE10137488A1 (de) * 2001-08-03 2003-02-20 Gruenenthal Gmbh Salze substituierter 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate
DE10137487A1 (de) * 2001-08-03 2003-03-27 Gruenenthal Gmbh Substituierte 5,6,6a,11b-Tetrahydro-7-oxa-6-aza- benzo[c]fluoren-6-carbonsäurederivate
JP2006508077A (ja) * 2002-10-04 2006-03-09 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 炎症疾患を治療するためのpgd2レセプタアンタゴニスト
US20090181966A1 (en) * 2002-10-04 2009-07-16 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
US7504508B2 (en) * 2002-10-04 2009-03-17 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
GB0327912D0 (en) * 2003-12-02 2004-01-07 Glaxo Group Ltd Medicament
CA2598133A1 (en) * 2005-02-24 2006-08-31 Millennium Pharmaceuticals, Inc. Pgd2 receptor antagonists for the treatment of inflammatory diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2024516C1 (ru) * 1989-02-02 1994-12-15 Яманути Фармасьютикал Ко., Лтд. Способ получения производного тетрагидробензимидазола или его фармацевтически приемлемой соли
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
EP0386839B1 (en) * 1989-03-08 1997-01-15 Merck Sharp & Dohme Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
US5231102A (en) * 1989-03-08 1993-07-27 Merck Sharp & Dohme, Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
US5529999A (en) 1994-03-04 1996-06-25 Eli Lilly And Company Antitumor compositions and methods of treatment
DK0854867T3 (da) 1995-09-29 2002-12-02 Glaxosmithkline Spa Tetrahydroquinoliner som NMDA-antagonister
GB9617305D0 (en) * 1996-08-17 1996-09-25 Glaxo Wellcome Spa Heterocyclic compounds
MY125037A (en) * 1998-06-10 2006-07-31 Glaxo Wellcome Spa 1,2,3,4 tetrahydroquinoline derivatives

Also Published As

Publication number Publication date
WO1999064411A1 (en) 1999-12-16
EE200000733A (et) 2002-06-17
NO20006227L (no) 2001-02-08
ATE301650T1 (de) 2005-08-15
IS5746A (is) 2000-11-30
CN1311785A (zh) 2001-09-05
HUP0102767A3 (en) 2003-01-28
CZ293605B6 (cs) 2004-06-16
CN1173970C (zh) 2004-11-03
EA003276B1 (ru) 2003-04-24
MY125037A (en) 2006-07-31
CA2334727C (en) 2009-08-04
BG105123A (en) 2001-11-30
DE69926632D1 (de) 2005-09-15
KR20010052722A (ko) 2001-06-25
IL140062A (en) 2007-05-15
BR9911145A (pt) 2001-03-06
PL197160B1 (pl) 2008-03-31
HUP0102767A2 (hu) 2001-12-28
ES2249010T3 (es) 2006-03-16
PE20000724A1 (es) 2000-08-17
NO321904B1 (no) 2006-07-17
EP1086093A1 (en) 2001-03-28
US20020052391A1 (en) 2002-05-02
NZ508638A (en) 2003-08-29
DE69926632T2 (de) 2006-01-19
PL344694A1 (en) 2001-11-19
NO20006227D0 (no) 2000-12-07
OA11564A (en) 2004-05-24
DK1086093T3 (da) 2005-11-28
KR100586762B1 (ko) 2006-06-08
TWI229079B (en) 2005-03-11
US6413985B1 (en) 2002-07-02
AU753867B2 (en) 2002-10-31
CZ20004587A3 (en) 2001-05-16
TR200003652T2 (tr) 2001-04-20
AU4509299A (en) 1999-12-30
AP2000002008A0 (en) 2000-12-31
EP1086093B1 (en) 2005-08-10
ID27845A (id) 2001-04-26
US6495566B2 (en) 2002-12-17
IL140062A0 (en) 2002-02-10
HRP20000845A2 (en) 2001-10-31
US6362199B1 (en) 2002-03-26
CO5080785A1 (es) 2001-09-25
CA2334727A1 (en) 1999-12-16
AR018632A1 (es) 2001-11-28
EA200001165A1 (ru) 2001-06-25
US20020169186A1 (en) 2002-11-14
JP2002517492A (ja) 2002-06-18

Similar Documents

Publication Publication Date Title
IL143782A0 (en) Quinoline derivatives
PL343420A1 (en) Quinoline derivatives
AP2001002041A0 (en) Quinoline derivatives
IL143859A0 (en) 1,2-annelated quinoline derivatives
HK1042295A1 (zh) 1h-咪唑並吡啶衍生物
HK1035716A1 (en) Quinoline derivatives
HK1022310A1 (en) Benzosulfone derivatives
GB9809664D0 (en) a-Ketoamide derivatives
IL128141A0 (en) Tetrahydroquinoline derivatives as eaa antagonists
IL137329A0 (en) Vla-4 antagonists
HK1034079A1 (en) Tetrahydroquinoline derivatives as glycine antagonists
EG23802A (en) 2-Phenylpyran-4-one derivatives
GB9815505D0 (en) Polypeptide derivatives
GB9827729D0 (en) Thieno-indole derivatives
SI1086093T1 (sl) Derivati tetrahidrokinolina kot antagonisti glicina
EP1061912A4 (en) PHENANTHROFURANDERIVATE
HK1042478A1 (zh) 2-氧代-2h-喹啉衍生物
GB9711030D0 (en) Quinoline leukrotriene antagonists
GB9922577D0 (en) Substituted phosphinate based peptide derivatives
PL341899A1 (en) Vla-4 antagonists
GB9808696D0 (en) Peptide derivatives
GB9816279D0 (en) Arylthiazolidinedione derivatives

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130608